Astellas finds another collaborator in small UK startup; Two Japanese biotechs align on gene therapies
After an immuno-oncology antibody deal, a cancer immunotherapy tie-up and a protein pact, Astellas Pharma is on to its next partnership, this …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
